Renovacor 주식 가격. RCOR - 주식 시세, 차트, 과거 거래, 주식 채팅, 재무.

다우존스 지수

무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.

등록

홈
인베스팅
주식
미국
AMEX
Renovacor Inc (RCOR) 시세

Renovacor Inc (RCOR)

3.20

0.00

(0.00%)

마감 15 2월 6:00AM

3.20

0.00

( 0.00% )

시간외 단일가: 9:00AM

실시간 스트리밍 인용문, 아이디어 및 실시간 토론을 위한 허브

가격

3.20

매수가

-

매도가

-

거래량

-

0.00 일간 변동폭 0.00

0.00 52주 범위 0.00

전일 종가

3.20

개장가

-

최근 거래 시간

마지막 거래 시간

-

평균 볼륨(3m)

-

재정 규모

-

VWAP

-

Renovacor Announces Upcoming Presentation at the 29th European Society of Gene & Cell Therapy Congress

Renovacor, Inc. (NYSE: RCOR), a biotechnology company focused on delivering innovative precision therapies to improve the lives of patients and...

Renovacor Announces Upcoming Presentation at Keystone Symposia’s Heart Failure: Mechanisms and Therapies Conference

Renovacor, Inc. (NYSE: RCOR), a biotechnology company focused on delivering innovative precision therapies to improve the lives of patients and...

Rocket Pharmaceuticals to Acquire Renovacor, Extending Leadership in AAV-based Cardiac Gene Therapy

Acquisition further strengthens Rocket’s leadership in AAV-based cardiac gene therapy and expands Company’s near-term clinical assets for the...

Renovacor Reports Second Quarter 2022 Financial Results and Provides Corporate Update

REN-001 IND submission planned for the second half of 2022 Data from pilot pig study showing successful cardiac transduction with REN-001...

Renovacor Announces Pipeline Expansion with New Research Program for Multiple Genetic Segments of Arrhythmogenic Cardiomyopathy

Research collaboration with the University of Utah's Nora Eccles Harrison Cardiovascular Research and Training Institute expands pipeline with...

Renovacor Announces Data from Pilot Pig Study Showing Successful Cardiac Transduction with REN-001 Delivered Via Low-Dose Retrograde Coronary Sinus Infusion Published in Journal of the American College of Cardiology: Basic to Translational Research

REN-001 delivered locally via low-dose retrograde coronary sinus infusion demonstrated robust, diffuse cardiomyocyte transduction in a large...

Renovacor Reports First Quarter 2022 Financial Results and Provides Corporate Update

REN-001 advancing toward IND submission in the second half of 2022 with the initiation of a Phase I/II clinical trial in BAG3-DCM expected...

기간	변동	변동 %	시가	고가	저가	평균 일일 거래량	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

RCOR - Frequently Asked Questions (FAQ)

What is the current Renovacor share price?

The current share price of Renovacor is US$ 3.20

What is the 1 year trading range for Renovacor share price?

Renovacor has traded in the range of US$ 0.00 to US$ 0.00 during the past year

가장 활성
% 상승자
% 패자

기호	가격	볼륨
RYDERyde Group Ltd	US$ 0.3772 (14.16%)	190
BGIBirks Group Inc	US$ 1.38 (14.05%)	629
ECFEllsworth Growth and Income Fund Ltd	US$ 11.37 (13.25%)	2
COE51Talk Online Education Group	US$ 23.99 (13.16%)	2
KALLKraneshares Msci All China Index ETF	US$ 24.96 (11.88%)	5
XDECFT Vest US Equity Enhance & Moderate Buffer ETF December	US$ 31.00 (-18.36%)	1
KAPAKairos Pharma Ltd	US$ 1.23 (-10.22%)	2.84k
SOARVolato Group Inc	US$ 0.17 (-9.43%)	10.56k
LODEComstock Inc	US$ 0.321 (-8.68%)	44.22k
GMARFT Vest US Equity Moderate Buffer ETF March	US$ 35.00 (-8.66%)	7
ETHU2x Ether ETF	US$ 4.40 (-2.65%)	881.45k
SOXLDirexion Daily Semiconductor Bull 3X Shares	US$ 29.10 (1.93%)	384.68k
FXIiShares China Large Cap	US$ 35.66 (1.77%)	364.25k
YINNDirexion Daily FTSE China Bull 3X Shares	US$ 42.96 (5.22%)	352.43k
TSLZT Rex 2X Inverse Tesla Daily Target ETF	US$ 2.795 (-2.44%)	324.49k

The Danish Dude

The Danish Dude 2 분 전

@flipper44

https://threadreaderapp.com/thread/1891787508855259274.html

SkeBallLarry

SkeBallLarry 4 분 전

" G'Morning " ~ 21degs ~ 2-4" coming, Capgain .. !!

TheFinalCD

TheFinalCD 14 분 전

https://x.com/Beppels1/status/1890449070923141202

The ELTP King

The ELTP King 15 분 전

Both are happening.

Nasdaq then buyout.

His intention is to suggest with certainty that we are headed for a reverse split and not a buyout.

TheFinalCD

TheFinalCD 15 분 전

GOOD CALL

GLYC BELL BUY INTO VOLUME AND BIG GAPPER

Cflores32097

Cflores32097 15 분 전

btw FP still owes all those investors he robbed

somberfox

somberfox 20 분 전

somberfox

somberfox 20 분 전

Cflores32097

Cflores32097 20 분 전

Oh yea 🦆🦆 is so 2022 we got a new scam

Cflores32097

Cflores32097 21 분 전

Hey Charles, what happened 🦆 🦆 go

Cflores32097

Cflores32097 21 분 전

LIONS GROUP CBD EVANS CYBER ZEN

Cflores32097

Cflores32097 25 분 전

Jzzi CBD HONEY GREG EVANS 55 UP

WolfofMia

WolfofMia 34 분 전

You don't have the energy, except for pompous reasons.

Got it.

longview1

longview1 35 분 전

My post keep getting removed, obviously making one of the Trump babies mad.

Dragonman1

Dragonman1 40 분 전

I hope we all benefit from this great beer co and see the awesome results in the report coming out soon, The bashers or the fool force is in for a big wake up call, northbound we go!

NickyCapone

NickyCapone 45 분 전

Warning‼️
All Shorties‼️

Last One Out is a Rotten Egg‼️

lakers17

lakers17 50 분 전

Yeah I feel the same way recently. Both the OTC and crypto are pissing me off. I keep buying more and more crypto on many of these dips. It's really boom or bust for me.

Guzzi62

Guzzi62 53 분 전

The main trial didn't fail dude, one primary endpoint failed, which is not the same.

That endpoint is in the process of being removed by the FDA which you likely knew already.

Why are you lying?

king_kong

king_kong 56 분 전

https://x.com/maxinvestor89/status/1891752794396229705?s=46&t=He3ILIizDMal7FFXIIgFjw

sharkey1

sharkey1 57 분 전

Correction, on the house bill 1396, copied from redit,

https://www.reddit.com/r/WallStreetbetsELITE/comments/1irl3m7/how_hr1396_could_impact_the_stock_market_generic/

can't find on google, it's in the ways and means committee
I think

capgain

capgain 59 분 전

Good morning, Larry, the cold is returning again.

walterc

walterc 59 분 전

mailconversation with IR
read the reply
- Appreciate your patience as we've worked to get you answers to some of these questions. Management is not in a position to provide an update on the commercial strategy with firm targets, timelines, etc. as that would constitute a material upda

valleybenedetto

valleybenedetto 60 분 전

There is ZERO dilution here. No warrants no overhead supply.

capgain

capgain 60 분 전

Happy Birthday, B2B!

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관